MIR6129

Across TCGA pan-cancer cohorts, MIR6129 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR6129’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MIR6129 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6129 is over-expressed in tumor.

LIHC, BRCA, and KIRP are the cancer types where MIR6129 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6129 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	III,IV	+0.487	.018	3	view →
BRCA	All	IV	+0.595	<.001	2	view →
KIRP	All	All	+0.174	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR6129–LIHC

Open the LIHC breakdown →